Last reviewed · How we verify
NCT06829862: LIO
Lifestyle Intervention on Patients With Overweight or Obesity
NA trial testing Own Doctor Education in Obesity in 115 participants. Completed in 11 May 2025.
11 May 2025
Quick facts
| Lead sponsor | Cardenal Herrera University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 115 |
| Start date | 11 February 2025 |
| Primary completion | 11 May 2025 |
| Estimated completion | 11 May 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Own Doctor Education
- Unknown Doctor Education
Conditions studied
- Obesity — all drugs for Obesity →
- Physical Activity — all drugs for Physical Activity →
- Eating Behavior — all drugs for Eating Behavior →
- Therapeutic Alliance — all drugs for Therapeutic Alliance →
Sponsor
Cardenal Herrera University
Who can join
Adults 18 to 65, any sex, with Obesity or Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to analyze the effects of a 3-month self-applied online program, focused on promoting healthy lifestyle habits (healthy eating and increased physical activity), on adults with obesity. Participants will be recruited by 8 doctors from 6 public Health Centers. These patients will be randomized allocated into two interventional groups: the experimental group will receive audiovisual instructions from their specialist doctor, and the control group from a doctor outside the patient. Assessment will include sociodemographic variables, body mass index, blood pressure, glycemic and lipid metabolism variables, physical activity level, adherence to the Mediterranean diet, therapeutic alliance, and health-related quality of life. The randomization process will be stratified according to BMI, therapeutic alliance, age, and sex.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06829862
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Cardenal Herrera University trials
Trials by the same sponsor.
- NCT07471269 — Online Pain Neuroscience Education For Fear Of Childbirth. · NA · recruiting
- NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
- NCT07499856 — Intradialytic Exercise Program Supported by Audiovisual Media Combined With Mindfulness · NA · enrolling by invitation
- NCT07275112 — Cross-cultural an Reliability and Validity Evaluation of TENDINS-A in Spain · completed
- NCT07133581 — Design and Validation of FEXO: A Playful Exercise Program for Institutionalized Frail Older Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06829862 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardenal Herrera University
- Last refreshed: 30 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06829862.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing